January 30th, 2015 8:00 AM-10:00 AM
Learn from Eitan Yudilevich, Ph.D. Director of U.S. – Israel Binational R & D Foundation (BIRD) about grants available to collaborate new high tech product development with Israeli companies. Grants up to $1 million are available to engage innovative companies from The Start Up Nation to kick start your company’s product development to a new level.While there is no fee, RSVPs are required.
New Jersey’s first private medical school in 50 years is planned for part of the 110-acre Hoffmann-La Roche property. Roche plans to vacate the land in 2015 after an 80-year history in Clifton and Nutley.
U.S. Senator Barbara A. Mikulski (D-Md.) today met with Governor-Elect Larry Hogan at Harry Brown’s Restaurant in Annapolis. Senator Mikulski and Governor-Elect Hogan discussed working together to support jobs and opportunity for Maryland families.
Novartis India has agreed to transfer its over-the-counter division (OTC Division) to GlaxoSmithKline Consumer (GSK CPL), a consumer healthcare joint venture (JV) between Swiss pharmaceutical firm Novartis and GSK, for about INR1.097bn ($17.6m)
The cash just keeps flowing in health IT, as does M&A activity.
According to Mercom Capital Group, venture capital in the health IT space reached $4.7 billion in 2014, up from $2.2 billion the year prior. Rock Health recently put the figure at $4 billion, although it’s count does not include deals under $2 million.
FierceBiotech on Wednesday delivered the first big verdict on the “mood” of the JP Morgan Healthcare Conference – based largely on its executive breakfast held this week in San Francisco. The verdict: Real confidence well above and beyond the typical happy face you’d get, regardless, at JP Morgan.
The Johns Hopkins University Applied Physics Laboratory (APL), in Laurel, Maryland, has received $4 million in funding from the Mann Fund to develop a next-generation retinal prosthesis system. The Mann Fund was created by philanthropist Alfred E. Mann 15 years ago to support the development of biomedical technologies.
In the summer of 2013, Pamela Shavaun Scott started having “24/7 severe headaches” — so severe that she couldn’t sleep. It wasn’t before December that she heard for sure that it was a brain tumor.
Harvard University has long played an outsized role in spurring the growth of the Boston area’s life sciences industry, but the school’s contributions have largely unfolded behind the scenes.
Unlike the Massachusetts Institute of Technology in Cambridge’s Kendall Square — the beating heart of biotech — Harvard has been known less for spinning off startups than for licensing cutting-edge research and grooming the industry’s business leaders.
A trio of scientists have started working with researchers at GlaxoSmitKline on a potential cure for cancer. In fact, they believe they’ve found the diseases’ “Achilles heel.”
Last month, GlaxoSmithKline (NYSE: GSK) selected a Wistar/Penn project for its 2014 Discovery Fast Track Challenge program, which was created to accelerate the development of new medicines.
